While this study suggests that BRD4 inhibition acts predominantly by reducing MDSC abundance and recruitment to the tumor, other work has shown that BRD4 inhibition can alter immune macrophage phenotypes (15, 16). This evidence concerns the gene BRD4 and neoplasm.